Company / EPS (Diluted)
Oruka Therapeutics, Inc. EPS (Diluted) History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$3.87
FY2024
5-year range
-$4.15 / -$0.69
FY2020-FY2024
Trend
-460.9%
vs FY2023
Sector context
#162 of 204
Health Care
What the data says
EPS (Diluted) changed -461% YoY in FY2024, a notable deviation from the 9-year average annual change of -78%.
Based on SEC 10-K filings.
-3.87 in FY2024.
Declined from $-1.39 to $-3.87 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 204This company -$3.87 Sector average -$0.98
▼
-295.1% below sector average
Key checks
Key Insights
- In FY2024, eps (diluted) decreased 460.9% year-over-year.
- Ranks #162 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$3.87 | -460.9% |
| FY2023 | -$0.69 | +50.4% |
| FY2022 | -$1.39 | +32.9% |
| FY2021 | -$2.07 | +50.1% |
| FY2020 | -$4.15 | +59.7% |
| FY2019 | -$10.31 | -482.5% |
| FY2018 | -$1.77 | +2.2% |
| FY2017 | -$1.81 | +0.5% |
| FY2016 | -$1.82 | +45.0% |
| FY2015 | -$3.31 | -218.3% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026